Regulacje i polityka gospodarcza · 2.12.2009

Findings of Research Misconduct

Notice is hereby given that the Office of Research Integrity (ORI) and the Assistant Secretary for Health have taken final action in the following case: Rashanda Robertson, Emory University: Based on an assessment conducted by Emory University (EU), the Respondent's own admission, and additional oversight of that admission conducted by ORI, ORI and EU found that Ms. Rashanda Robertson, former Research Coordinator, Department of General Medicine, EU, engaged in research misconduct in research supported by National Heart, Lung, and Blood Institute (NHLBI), National Institutes of Health (NIH), grant K23 HL077597. The randomized study for which she coordinated was designed to assess whether patient medication compliance was improved by a meeting with a clinical pharmacist to discuss the patient's current and newly prescribed medications prior to the patient's discharge from the hospital. The enrolled subjects randomized to the intervention group received a card listing all of their medications and a "pill box" to help them with medication compliance. The subjects also were called three days after discharge to check on their medication compliance. Specifically, the U.S. Public Health Se